Edwards Lifesciences Stock Forecast & Price Target
Edwards Lifesciences Price Target 2026
The Quantum Forecast sees a price target of $104.54 (+2.4%) for Edwards Lifesciences in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $102.08. Click to see the forecast in the chart.
Edwards Lifesciences Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Edwards Lifesciences at $102.02 (−0.15%) today around 10 AM ET and at $102.06 (−0.10%) today around 3 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Edwards Lifesciences Stock 2026: Price Performance
Edwards Lifesciences stock has gained 19.7% since the start of 2026 and currently trades at $102.08 (as of Nov 11, 2026). Over the same period the S&P 500 is up 11.0%, putting the stock 8.7 percentage points ahead of the index. Over the past 52 weeks the price ranged between $74.73 and $104.88; it is currently 2.7% below its high of Nov 9, 2026.
Edwards Lifesciences Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $94.11 for Edwards Lifesciences – −7.8% from today. The range band runs from $69.28 – $118.94: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Edwards Lifesciences
There are no user forecasts for Edwards Lifesciences yet – be the first to make one.
Make your own forecastAbout Edwards Lifesciences
Edwards Lifesciences Corporation develops medical devices for structural heart disease. Headquartered in Irvine, California, it traces its origins to the 1958 partnership of engineer Miles "Lowell" Edwards and surgeon Albert Starr, who developed one of the first artificial heart valves. Edwards was spun off from Baxter International in 2000. Its largest business is transcatheter aortic valve replacement (TAVR) with the SAPIEN valve family, which allows replacement of a diseased aortic valve through a catheter without open-heart surgery. Other units cover transcatheter mitral and tricuspid therapies and surgical heart valves.
Customers are hospitals and cardiac surgery centers, with the United States as the largest market, followed by Europe and Japan. In 2024 Edwards sold its Critical Care unit to BD to focus on structural heart. Growth themes include expanded TAVR indications such as asymptomatic patients, new devices for mitral and tricuspid valves, and competition from Medtronic, Boston Scientific and Abbott. Edwards trades on the NYSE under the ticker EW and is a member of the S&P 500.
The current price of Edwards Lifesciences stock is $102.08 (−2.12% vs. the previous close). In today's trading the high was $104.69 and the low $102.07.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Edwards Lifesciences Stock
What is the Edwards Lifesciences stock forecast?
The Quantum Forecast expects Edwards Lifesciences to reach $104.54 in about one month (by Dec 10, 2026), a change of +2.4% from the current price of $102.08. Over roughly 10 months (by Sep 2027) the price target is $94.11 (−7.8%).
What is the Edwards Lifesciences stock price target?
Quantum Forecast price targets by time frame: 1 month $104.54 (+2.4%), 2 months $97.84 (−4.1%), 6 months $95.95 (−6.0%), 10 months $94.11 (−7.8%). The range band shows the typical fluctuation around these targets.
Will Edwards Lifesciences stock go up or down?
In the short term the Quantum Forecast points up (+2.4% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Edwards Lifesciences?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.